CI
CVI Investments, Inc. disclosed a 9.9% stake in MBRX
CVI Investments, Inc. reported owning 9.9% of Moleculin Biotech, Inc. (MBRX) (2,161,749 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G